Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 5
1967 2
1968 3
1969 2
1971 5
1972 4
1973 1
1974 11
1975 1
1976 2
1977 4
1978 14
1979 9
1980 9
1981 10
1982 15
1983 30
1984 28
1985 34
1986 27
1987 38
1988 32
1989 20
1990 11
1991 11
1992 7
1993 5
1994 7
1995 4
1996 4
1997 4
1998 4
1999 9
2000 7
2001 1
2002 1
2003 4
2004 1
2005 1
2006 1
2007 2
2008 2
2010 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 6367917

397 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA. Winston DJ, et al. Bone Marrow Transplant. 2001 Jul;28(2):187-96. doi: 10.1038/sj.bmt.1703109. Bone Marrow Transplant. 2001. PMID: 11509937 Clinical Trial.
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F. Ringdén O, et al. J Clin Oncol. 2004 Feb 1;22(3):416-23. doi: 10.1200/JCO.2004.06.102. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691124
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harrousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC. Ringdén O, et al. Bone Marrow Transplant. 1996 Nov;18(5):921-9. Bone Marrow Transplant. 1996. PMID: 8932846
Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K. Inamoto Y, et al. Biol Blood Marrow Transplant. 2008 Jan;14(1):43-9. doi: 10.1016/j.bbmt.2007.06.015. Epub 2007 Dec 3. Biol Blood Marrow Transplant. 2008. PMID: 18158960 Free article.
397 results